In line with these observations, human thyroid cancer cell lines responded to selenide treatment by cell cycle arrest in the S and G2/M phases, which was accompanied by the upregulated expression of DNA damage response factors GADD34/PPP1R15A and GADD153/DDIT3 [87]. This evidence concerns the gene PPP1R15A and thyroid gland carcinoma.